Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Pharmaceutical company trials and the integrity of medical research — Luc Tritsmans (1996) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Pharmaceutical company trials and the integrity of medical research
Shared by
David Moher
Pharmaceutical company trials and the integrity of medical research
Letter
1996
en
Authors
+4 more
LT
Luc Tritsmans
PB
P. Briscoe
PL
P. Lemmens
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
1996
Redundancy, disaggregation, and the integrity of medical research
Patricia Huston
,
David Moher
Article
2018
Maintaining Research and Publication Integrity
Nader Rifai
,
Thomas M Annesley
,
S Breanndan Moore
,
Arthur L. Caplan
,
Deborah Sweet
,
Peter Hornung
,
Frits R. Rosendaal
Clinical Chemistry
Article
2024
Research Integrity definitions and challenges
Anna Catharina Vieira Armond
,
Kelly D. Cobey
,
David Moher
Article
2024
Investigating the Applications of Deep Learning in Drug Discovery and Pharmaceutical Research
Karishma Desai
,
Manish Kumar Goyal
,
M N Nachappa
Letter
2022
Lessons from the COVID-19 pandemic and recent developments on the communication of clinical trials, publishing practices, and research integrity: in conversation with Dr. David Moher
Daeria O. Lawson
,
Michael Ke Wang
,
Kevin Kim
,
Rachel Eikelboom
,
Myanca Rodrigues
,
Daniela Trapsa
,
Lehana Thabane
,
David Moher
.webp){kind=small}
Discussion(0)
No comments yet. Be the first to comment.